Ronald M Kurtz MD

CIK 1295469 · View on SEC EDGAR ↗

Insider

First SEC filing: July 29, 2021 · Latest: July 29, 2021

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 12 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

12 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 3, 2024 RXST S 10b5-1 40,000 $60.15 $2,406,000 764,610 Indirect -4.97% Disposed -89.9% (price as of 2026-08-21)
Jan. 8, 2024 RXST S 10b5-1 31,250 $45.00 $1,406,250 804,610 Indirect -3.74% Disposed -86.5% (price as of 2026-08-21)
Jan. 8, 2024 RXST S 10b5-1 31,250 $43.50 $1,359,375 835,860 Indirect -3.60% Disposed -86.1% (price as of 2026-08-21)
Dec. 27, 2023 RXST S 10b5-1 22,500 $41.09 $924,525 867,110 Indirect -2.53% Disposed -85.3% (price as of 2026-08-21)
Dec. 14, 2023 RXST S 10b5-1 20,000 $39.40 $788,000 889,610 Indirect -2.20% Disposed -84.6% (price as of 2026-08-21)
Dec. 14, 2023 RXST S 10b5-1 20,000 $40.01 $800,200 909,610 Indirect -2.15% Disposed -84.9% (price as of 2026-08-21)
Aug. 5, 2021 RXST P 3,638 $13.85 $50,386 804,610 Indirect +0.45% Acquired -56.2% (price as of 2026-08-21)
Aug. 3, 2021 RXST P 125,000 $16.00 $2,000,000 125,000 Direct — Acquired -62.1% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Feb. 27, 2026 RXST Restricted Stock Unit Common Stock (80,545) — — 80,545 Acquired
Feb. 27, 2025 RXST Stock Option (right to buy) Common Stock (215,000) $28.21 Feb. 26, 2035 215,000 Acquired
Aug. 9, 2024 RXST Stock Option (right to buy) Common Stock (2,300) $4.34 March 13, 2027 2,300 Disposed
Aug. 9, 2024 RXST Stock Option (right to buy) Common Stock (7,650) $15.08 April 22, 2030 7,650 Disposed
July 11, 2024 RXST Stock Option (right to buy) Common Stock (13,500) $15.08 April 22, 2030 13,500 Disposed
March 4, 2024 RXST Stock Option (right to buy) Common Stock (149,000) $56.07 March 3, 2034 149,000 Acquired
March 9, 2023 RXST Stock Option (right to buy) Common Stock (200,000) $14.95 March 9, 2033 200,000 Acquired
July 31, 2021 RXST Stock option (right to buy) Common Stock (338,819) $16.00 July 31, 2031 338,819 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 4 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
July 29, 2021 RXST Common Stock 800,972 Indirect
July 29, 2021 RXST Stock Option (right to buy)→ Common Stock (2,299) 2,299 Direct
July 29, 2021 RXST Stock Option (right to buy)→ Common Stock (40,335) 40,335 Direct
July 29, 2021 RXST Stock Option (right to buy)→ Common Stock (96,805) 96,805 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

RXST

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2023 $633,333 — — $1,873,660 $570,000 — $4,604 $3,081,597
2022 $562,500 — — — $457,566 — $5,405 $1,025,471
2021 $445,293 $375,000 — — — — — —

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.